TP53 and neoplasm: For example, the mutational frequency of TP53 in HCC in the TCGA cohort is significantly different between different racial and ethnic groups (Black or African Americans, 70.6%, Asians, 36.5%, and Caucasians, 22.8%) [112], suggesting differential tumor drivers according to the population of origin.